Home › Funds › Jones Hill Capital LP › AVLN
Jones Hill Capital LP position in AVLN
AVALYN PHARMACEUTICALS INC · Health Care
Jones Hill Capital LP reported holding 126,744 shares of AVLN (AVALYN PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.61% of its reported portfolio and ranking #27 among its reported holdings. Jones Hill Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's AVLN position evolved
Jones Hill Capital LP first disclosed a stake in AVLN in Q3 2026 at 126,744 shares (US$3.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 126.74K | $3.61M | New |
About AVLN and 13F data
AVLN (AVALYN PHARMACEUTICALS INC) is a Health Care company. 113 other funds we track also report a position in AVLN — the largest reported positions include Novo Holdings A/S (US$127.8M), SR ONE CAPITAL MANAGEMENT, LP (US$108.9M), PERCEPTIVE ADVISORS LLC (US$88.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVLN
- Novo Holdings A/S 3.88M sh · $127.84M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 3.31M sh · $108.92M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.68M sh · $88.07M · Q2 2026
- MONTANOVA CAPITAL, LLC 2.50M sh · $82.40M · Q2 2026
- NVP Associates, LLC 2.27M sh · $74.68M · Q2 2026
- Catalio Capital Management, LP 1.68M sh · $55.17M · Q2 2026
- Bellevue Group AG 1.35M sh · $44.44M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 966.79K sh · $31.83M · Q2 2026
- Andera Partners 929.82K sh · $26.49M · Q3 2026
- BRAIDWELL LP 801.39K sh · $26.38M · Q2 2026
- TPG GP A, LLC 773.07K sh · $25.45M · Q2 2026
- Rock Springs Capital Management LP 662.92K sh · $21.82M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held AVLN?
Jones Hill Capital LP has disclosed AVLN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Jones Hill Capital LP's current position in AVLN?
As of Q3 2026, Jones Hill Capital LP holds 126.74K shares of AVLN (AVALYN PHARMACEUTICALS INC), valued at $3.61M, representing 0.61% of its reported portfolio and ranking #27.
Has Jones Hill Capital LP been buying or selling AVLN?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in AVLN.
Which other funds hold AVLN?
Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, among 113 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.